Skip to Content
COVID-19 Response and Update
International
  • About
        • AboutWe challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • The Amneal Patient Assistance Program
          • Product Donations
          • National and Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
  • Products
        • ProductsWe produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
        • Amneal Investors
  • News
  • Careers
        • CareersJoin our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals

Adverse Event Reporting

Defining and reporting an adverse event

Please contact us if you experience an adverse event associated with the use of an Amneal or Impax product. The following should be reported to Amneal whether or not they are associated with an adverse event:

  • Off-label use of an Amneal or Impax product relates to situations where the medicinal product is intentionally used for a medical purpose not in accordance with the approved product information
  • Accidental or intentional medication errors or overdose of an Amneal or Impax product
  • Misuse, where the Amneal or Impax product is intentionally and inappropriately used not in accordance with the approved product information
  • Abuse, which is persistent or sporadic, intentional excessive use of a medicinal product
  • Reports of patient death after exposure to an Amneal or Impax product where no other details are provided
  • Occupational exposure to an Amneal or Impax product
  • Transmission of an infectious agent through a contaminated Amneal or Impax product

 

To Report an Adverse Event

If you are currently experiencing a life-threatening event, please immediately call 9-1-1.

To report an adverse event related to an Amneal, Impax and/or Gemini Laboratories Product:

Contact the Amneal Drug Safety team at (877) 835-5472, option 3 or at DrugSafety@amneal.com.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call (800) FDA-1088.

  • Privacy Notice
  • Privacy Shield
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • Linkedin
  • NABP DDA Accreditation
© 2021 Amneal Pharmaceuticals LLC.
All rights reserved.
We use cookies for statistical and measurement purposes, to help improve our website and to allow us and our partners to provide you with more relevant information. By continuing
to navigate this site, closing this box, or by clicking here you are indicating your consent to our use of cookies. To find out more, including how to withdraw your consent, click here
ACCEPTREFUSE
Revoke cookies